Home | All results_reference

[RDF data]
Results Reference #1325

Resource URI: http://static.linkedct.org/resource/results_reference/1325
linkedct:citation Ortonne JP, Sterry W, Tasset C, Reich K. Certolizumab pegol, the first pegylated anti-TNF alpha, is effective and well tolerated in patients with moderate-to-severe chronic plaque psoriasis: preliminary data from a phase II study. J.Eur.Acad.Dermatol.Venereol. 21[Suppl 1], 26. 2007. Rhodes, Greece, 15th Congress of the European Academy of Dermatology and Venereology (EADV), October 4-8, 2006.
rdfs:label Results Reference #1325
is linkedct:results_reference of <http://static.linkedct.org/resource/trials/NCT00245765>
linkedct:results_reference_id 1325 (xsd:int)
rdf:type linkedct:results_reference